HappeningToo topic
Ruxolitinib reports
Browse community reports connected to Ruxolitinib. These reports can show that other people are describing similar experiences, but they do not prove that Ruxolitinib caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
34 problems
Abdominal Discomfort while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and abdominal discomfort appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and abdominal distension appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and abdominal pain upper appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and abdominal pain appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and alopecia appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and anxiety appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and back pain appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and chills appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and constipation appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and cough appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and decreased appetite appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and dehydration appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and diarrhea appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and dizziness appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and dry skin appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and fatigue appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and feeling abnormal appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flatulence while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and flatulence appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and headache appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and insomnia appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and itching appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and malaise appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and muscle spasms appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and myalgia appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and nausea appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Night Sweats while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and night sweats appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and pain appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and rash appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and shortness of breath appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and sleepiness appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and vomiting appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and weakness appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and weight decreased appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Ruxolitinib
FDA FAERS contains adverse-event reports in which Ruxolitinib and weight increased appear together. This does not establish that Ruxolitinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →